科学出版物

Pre-clinical Development of Elsulfavirine/VM1500A Long Acting Injectable Formulations (EACS 2017)

Pre-clinical Pharmacokinetics of Elsulfavirine/VM1500A Long Acting Injectable Formulations (IAS 2017)

Elsulfavirine as Compared to Efavirenz in Combination with TDF/FTC: 48 Week Study (CROI 2017)

PE7/4 Safety and Antiviral Effect of Elpida (VM-1500), a Novel NNRTI (+ Truvada) in Treatment-Naive HIV-1 Infected Patients (EACS 2015)

A Randomized, Placebo-Controlled, Double-Blind Study of VM-1500 in HIV-Naive Patients (CROI 2014)

Pharmacokinetics of VM-1500 20 mg and 40 mg in Healthy and HIV-Infected Patients (AIDS 2014)